Journal
JOURNAL OF IMMUNOLOGY
Volume 193, Issue 6, Pages 2821-2830Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1302498
Keywords
-
Categories
Funding
- National Institutes of Health [CA164062, AI053825, CA155823, AI 091965]
- National Institutes of Health Institutional Postdoctoral Training Award [AI049823]
- University of Vermont start-up funding
- Trudeau Institute
Ask authors/readers for more resources
TLR-mediated activation of dendritic cells (DCs) is associated with a metabolic transition in which mitochondrial oxidative phosphorylation is inhibited by endogenously synthesized NO and the cells become committed to glucose and aerobic glycolysis for survival. We show that inhibition of mechanistic target of rapamycin (mTOR) extends the lifespan of TLR-activated DCs by inhibiting the induction of NO production, thereby allowing the cells to continue to use their mitochondria to generate ATP, and allowing them the flexibility to use fatty acids or glucose as nutrients to fuel core metabolism. These data provide novel mechanistic insights into how mTOR modulates DC metabolism and cellular longevity following TLR activation and provide an explanation for previous findings that mTOR inhibition enhances the efficacy of DCs in autologous vaccination.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available